Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for ...

Retrieved on: 2021-04-12 17:48:45

Tags for this article:

Clinical trials

Health sciences

Herpes simplex research

Sputnik V COVID-19 vaccine

Dna Sciences Inc

Applied DNA Sciences

Click the tags to see associated articles and topics

Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for .... View article details on HISWAI: https://pipelinereview.com/index.php/2021041377926/Vaccines/Applied-DNA-and-Evvivax-Announce-Positive-Preliminary-Results-of-Phase-I-Clinical-Trial-for-LinearDNA-COVID-19-Vaccine-Candidate-in-Felines.html

Excerpt

STONY BROOK, NY, USA & ROME, Italy I April 12, 2021 IApplied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in ...

Article found on: pipelinereview.com

View Original Article